Opening Recap Market Pulse: Tech stocks drifted lower as US-China tariff talks reignited, putting growth names on edge. Key Movers: Tesla took the brunt amid
Overview and Background Gossamer Bio (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company focused on developing seralutinib, an inhaled therapy for pulmonary arterial hypertension (PAH) (robbinsllp.com)
Daily Financial Update Market Pulse: Energy and tension surged on the Street yesterday as Tesla’s buy-vs-sell debate dominated chatter, sending swings even as broad sentiment
